Pfizer Inc. buy Konrad
Start price
03.01.22
/
50%
€50.01
Target price
03.01.23
€78.00
Performance (%)
-2.98%
End price
04.01.23
€48.52
Summary
This prediction ended on 04.01.23 with a price of €48.52. With a performance of -2.98%, the BUY prediction for Pfizer Inc. by Konrad closed slightly in the red. Dividends of €1.55 are taken into consideration when calculating the performance. Konrad has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -2.727% | -2.727% | -32.311% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Konrad what are the pros and cons of Pfizer Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
High Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Higher EBIT margin than peer group
High dividend yield expected
Very positive Cash Flow expected
Good rating
Leading role in innovation
Strong uniques
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Market Leader or Top 3
Small cyclical dependencies
Very Future proof/growth oriented business model
Cons
Comments by Konrad for this prediction
In the thread Pfizer Inc. diskutieren
Buy Pfizer Inc.
Kursziel gesetzt auf 78,0
In the thread Trading Pfizer Inc.
Die von Konrad gewählte maximale Laufzeit wurde überschritten